Open AccessLower-Cost Alternative Drugs Can Be Used Without Compromising Quality
Author(s) -
Mark L. Fuerst
Publication year - 2022
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000892596.15149.f3
Subject(s) - prior authorization , medicaid , biosimilar , medicine , payment , medical prescription , health care , pharmaceutical care , cancer drugs , specialty , quality (philosophy) , pharmacy , family medicine , business , drug , nursing , pharmacology , finance , philosophy , epistemology , economics , economic growth